X0306 4 2019-02-26 0 0001237831 GLOBUS MEDICAL INC GMED 0001190128 TOBIN JAMES R VALLEY FORGE BUSINESS CENTER 2560 GENERAL ARMISTEAD AVENUE AUDUBON PA 19403 1 0 0 0 Class A Common Stock 2019-02-26 4 M 0 8900 24.75 A 8900 D Class A Common Stock 2019-02-26 4 S 0 8500 47.06 D 400 D Class A Common Stock 2019-02-26 4 S 0 400 47.91 D 0 D Class A Common Stock 2019-02-28 4 M 0 6100 24.75 A 6100 D Class A Common Stock 2019-02-28 4 M 0 20000 25.52 A 26100 D Class A Common Stock 2019-02-28 4 M 0 2000 26.27 A 28100 D Class A Common Stock 2019-02-28 4 S 0 18800 48.10 D 9300 D Class A Common Stock 2019-02-28 4 S 0 9300 47.04 D 0 D Stock Option (Right to Buy Class A Common Stock) 24.75 2019-02-26 4 M 0 8900 0.00 D 2025-08-28 Class A Common Stock 8900 6100 D Stock Option (Right to Buy Class A Common Stock) 24.75 2019-02-28 4 M 0 6100 0.00 D 2025-08-28 Class A Common Stock 6100 0 D Stock Option (Right to Buy Class A Common Stock) 25.52 2019-02-28 4 M 0 20000 0.00 D 2026-01-25 Class A Common Stock 20000 0 D Stock Option (Right to Buy Class A Common Stock) 26.27 2019-02-28 4 M 0 2000 0.00 D 2027-01-30 Class A Common Stock 2000 23000 D The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $46.83 to $47.56, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1) to this Form 4. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $48.00 to $48.33, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4. These options were granted on August 28, 2015, and vested over a three-year period with one-twelfth (1/12) of the options granted vesting on December 31, 2015, and the balance of the options granted vesting ratably on a quarterly basis over the following 11 quarters. These options vest over a three-year period with one-twelfth (1/12) of the options granted vesting on March 31, 2016, and the balance of the options vesting ratably on a quarterly basis over the following 11 quarters. These options vest over a three-year period with one-twelfth (1/12) of the options granted vesting on March 31, 2017, and the balance of the options granted vesting ratably on a quarterly basis over the following 11 quarters. /s/ Kelly G. Huller, Attorney-in-Fact 2019-02-28